Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 881-896

  Heyes, Melvyn P ^a   Saito, Kuniaki ^a   Lackner, Andrew ^b   Wiley, Clayton A ^c   Achim, Cristian L ^c   Markey, Sanford P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Astrocytes; Blood brain barrier; Cytokines; Indoleamine 2,3 dioxygenase; Kynurenic acid; Kynureninase; Kynurenine aminotransferase; Kynurenine 3 hydroxylase; L kynurenine; L tryptophan; Macrophages; Nonhuman primates; Retrovirus

Indexed keywords

CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; KYNURENINASE; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; KYNURENINE AMINOTRANSFERASE; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFLAMMATION; MACACA; MACROPHAGE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RHESUS MONKEY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; PRIMATES; UNIDENTIFIED RETROVIRUS;

EID: 0031748985     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.10.981     Document Type: Article

References (72)

1. Spencer, D. C., and Price, R. W. (1993) Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46, 655-693
2. Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., and Chen, I. S. (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular trop isms. Science 236, 819-822
3. Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., Rubinow, D., and Maxkey, S. P. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann. Neurol. 29, 202-209
4. Genis, P., Jett, M. Bernton, E. W., Boyle, T., Gelbard, H. A., Dzenko, K., Keane, R. W., Resnick, L., Mizrachi, Y., Volsky, D. J., Epstein, L. G., and Gendelman, H. E. (1992) Cytokines and arachidonic acid metabolites produced during human immiunodeficiency virus. (HIV)-infected macrophage-astrbcyte interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 1703-1718.
5. Tyor, W. R., Glass, J. D., Griffin, J. W., Becker, P. S., McArthur, J. C., Bezman, L., and Griffin, D. E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360
6. Adamson, D. C., Wildemann, B., Sasaki, M., Class, J. D., McArthur, J. C., Christov, V. I., Dawson, T. M., and Dawson, V. L. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917-1921
7. Koka, P., He, K., Zack, J. A., Kitchen, S., Peacock, W., Fried, I., Tran, T., Yashar, S. S., and Merrill, J. E. (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor-α, and nitric oxide in glal cultures ferived from fetal, neonatal, and adult human brain. J. Exp. Med. 182, 941-952
8. Bukrinsky, M. I., Nottet, H. S. L. M., Schmidtmayerova, H., Dubrovsky, L., Flanagan, C. R., Mullins, M. E., Lipton, S. A., and Gendelman, H. E. (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HFV-1)-infected monocytes: implications for HIV-assodated neurological disease. J. Exp. Med. 181, 735-745
9. Brenneman, D. E., Westbrook, G. L., Fitzgerald, S. P., Ennist, D. L., Elkins, K. L., Ruff, M.R., and Pert, C. B. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (London) 335, 639-642
10. Dreyer, E. B., Kaiser, P. K., Offermann, J. T., and Lipton, S. A. (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science248, 364-367
11. Hayman, M., Arbuthnott, G., Harkiss, G., Brace, H., Filippi, P., Philippon, V., Thomson, D., Vigne, R., and Wright, A. (1993) Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus. Neuroscience 53, 1-6
12. Ghilian, D., Vaca, K., and Noonan, C. A. (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science250, 1593-1596
13. Giulian, D., Yu, J., Tom, D., Li, J., Wendt, E., Lin, S.-N., Schwarcz, R., and Noonan, C. (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16, 3139-3153
14. Pulliam, L., Herndier, B. G., Tang, N. M., and McGrath, M. S. (1991) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87, 503-512
15. Tardieu, M., H:ery, C., Peudenier, S., Boespflug, O., and Montagnier, L. (1992) Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32, 11-17
16. Stone, T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 45, 309-379
17. Heyes, M. P., Jordan, E. K., Lee, K., Saito, K., Frank, J. A., Snoy, P. J., Markey, S. P., and Gravell, M. (1992) Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid and serum quinolinic acid and kynurenic acid. Brain Res. 570, 237-250
18. Heyes, M. P., Saito, K., Crowley, J., Davis, L. E., Demitrak, M. A., Der, M., Dilling, L., Kruesi, M. J. P., Lackner, A., Larsen, S. A., Lee, K., Leonard, H., Markey, S. P., Martin, A., Milstien, S., Mouradian, M. M., Pranzatelli, M. R., Qucarry, B. J., Salazar, A., Smith, M., Straus, S. E., Sunderland, T., Swedo, S., and Tourtellotte, W. W. (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain. 115, 1249-1273
19. 2-microglobulin in cerebrospinal fluid and serum of HIV-1 infected patients. J. Neuroimmunol. 40, 71-80
20. Brouwers, P., Heyes, M. P., Moss, H., Wolters, P., El-Amin, D., Poplack, D., Markey, S. P., and Pizzo, P. (1993) Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type-1 disease: relationships to clinical status and therapeutic response. J. Infect. Dis. 168, 1380-1386
21. Martin, A., Heyes, M. P., Salazar, A. M., Law, W. A., and Williams, J. (1993) Impaired motor-skill learning, slowed reaction time, and elevated cerebrospinal fluid quinolinic acid in a sub-group of HIV-infected individuals. Neuropsychology 7, 149-147
22. Martin, A., Heyes, M. P., Salazar, A. M., Kampen, D. L., Williams, J., Law W. A., Coates, M. E., and Markey, S. P. (1992) Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J. Neuropsych. Clin. Neurosci. 4, 270-279
23. Rausch, D. M., Heyes, M. P., Murray, E. A., Lendvay, J., Sharer, L. R., Ward, J. M., Rehm, S., Nohr, D., Weihe, E., and Eiden, L. E. (1994) Cytopathologic and neurochemical correlates to motor/cognitive impairments in SIV-infected rhesus monkeys. J. Neuropathol. Exp. Neurol. 53, 165-175
24. Smith, M. O., Heyes, M. P., and Lackner, A. A. (1995) Early intrathecal events in rhesus macaques (Macaca Mulata) infected with pathogenic or non pathogenic strains of simian immuno-deficiency virus (SIV). Lab. Invest. 72, 547-558
25. Lane, J. H., Sasseville, V. G., Smith, M. O., Vogel, P., Pauley, D. R., Heyes, M. P., and Lackner, A. A. (1996) Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol. 2, 423-432
26. Heyes, M. P., Swartz, K. J., Markey, S. P., and Beal, M. F. (1991) Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci. Lett. 122, 265-269
27. Mouradian, M. M., Heyes, M. P., Pan, J.-B., Heuser, I. J. E., Markey, S. P., and Chase, T. N. (1989) No changes in central quinolinic acid levels in Alzheimer's disease. Neurosci. Lett. 105, 233-238
28. Heyes, M. P., Saito, K., Devinsky, O., and Nadi, S. N. (1994) Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex parital seizures. Epilepsia 35, 251-257
29. Nottet, H. S., Flanagan, E. M., Flanagan, C. R., Gelbard, H. A., Gendelman, H. E., and Reinhard, J. F. (1996) The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirol. 2, 111-117
30. Brew, B. J., Corbiel, J., Pemberton, L., Evans, L., Saito, K., Penny, R., Cooper, D. A., and Heyes, M. P. (1995) Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J. Neurovirol. 1, 328-374
31. Espey, M. G., Chernyshev, O. N., Reinhard, J. F., Namboodiri, M. A., and Colton, C. A. (1997) Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 20, 431-434
32. Heyes, M. P., Chen, C. Y., Major, E. O., and Saito, K. (1997) Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326, 351-356
33. Heyes, M. P., Saito, K., and Markey, S. P. (1992) Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283, 633-635
34. Heyes, M.P., Saito, K., Chen, C. Y., Proescholdt, M.G., Nowak, T.S., Li, J., Beagles, K.E., Proescholdt, M. A., Zito, M. A., Kawai, K., and Markey, S. P. (1997) Species heterogeneity between gerbils and rats: Quinolinate production by microglia and astrocytes, and accumulations in response to ischemic brain injury and systemic immune activation. J. Neurochem. 69, 1519-1529
35. Heyes, M. P., Achim, C., Wiley, C. A., Major, E. O., Saito, K., and Markey, S. P. (1996) Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 320, 595-597
36. Bender D. A. (1982) Biochemistry of tryptophan in health and disease. Mol Aspects Med. 6, 101-197
37. Heyes, M. P., and Morrison, P. F. (1997) Quantification of local de novo synthesis vs. blood contributions to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68, 280-288
38. Heyes, M. P., and Markey, S. P. (1988) Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-trypiophan administration on brain and blood quinolinic acid concentrations. Anal. Biochem. 174, 349-359
39. 18O]-Quinolinic acid: its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed. Environ. Mass. Spectrom. 15, 291-293
40. Heyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., and Vickers, J. H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: Attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116, 1425-1450
41. Wiley, C. A., and Achim, C. L. (1994) HIV encephalitis is the pathological correlate of dementia in AIDS. Ann. Neurol. 36, 673
42. Whetsell, W.O., and Schwarcz, R. (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97, 271-275
43. Saito, K., Crowley, J. S., Markey, S. P., and Heyes, M. P. (1993) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503
44. Saito, K., Markey, S. P., and Heyes, M. P. (1992) Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse. NeuroScience 51, 25-39
45. Boni, R. L., Heyes, M. P., Bacher, J. D., Yergey, J. A., Ji X.-D., Abramson, F. P., and Markey, S. P. (1989) Stable isotope-labeled tryptophan as a precursor for studying the disposition of quinolinic acid in rabbits. 6th Interna tlimai Study Group for Tryptophan Research. Kynurenine and Serotonin Pathways (Schwarcz, R., Young, S. N., and Brown, R. R., eds) pp. 481-484
46. Heyes, M. P., Saito, K., Jacobowitz, D., Takikawa, O., Markey, S. P., and Vickers, J. (1992) Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6, 2977-2989
47. Blight, A. R., Cohen, T. I., Saito, K., and Heyes, M. P. (1995) Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118, 735-752
48. Saito, K., Nowak, T. S., Jr., Markey, S. P., and Heyes, M.P. (1993) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60, 180-192
49. Beagles, K. E., Morrison, P. F., and Heyes, M. P. (1998) Quinolinic acid in vivo synthesis rates, extracellular fluid concentrations and intercompartmental distributions in normal and immune activated brain as determined by multiple isotope microdialysis. J. Neurochem. 70, 281-291
50. Heyes, M. P., and Lackner, A. (1990) Increased cerebrospinal fluid quinolinic acid, kynurenic acid and L-kynurenine in acute septicemia. J. Neurochem. 55, 338-341
51. Saito, K., Markey S. P., and Heyes, M. P. (1991) Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res. 546, 151-154
52. Sei, Y., Paul, I. A., Saito, K., Layar, R., Hartley, J. W., Hartley, J. W., Morse, H. C., Skolnick, P., and Heyes, M.P. (1995) Quinolinic acid levels in a murine retrovirus-induced immunodeficiency syndrome. J. Neurochem. 66, 296-302
53. Petito, C. K., and Cash, K. S. (1992) blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32, 658-666
54. Saito, K., Chen, C.Y., Masana, M., Crowley, J., Markey, S. P., and Heyes, M. P. (1993) 4-Chloro-3-hydroxyanthranilic acid, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ stimulated monocytes (THP-1) cells. Biochem. J. 291, 11-14
55. Naritsin, D. B., Saito, K., Markey, S. P., and Heyes, M. P. (1995) Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. J. Neurochem. 65, 2217-2226
56. Taylor, M. W., and Feng, G. (1991) Relationship between interferon-γ, indoleamine-2,3-dioxygenase and tryptophan. FASEB J. 5, 2516-2522
57. Heyes, M. P., and Quearry, B. J. (1990) Quantification of kynurenic acid in cerebrospinal fluid: effects of systemic and central L-kynurenine administration. J. Chromatogr. 530, 108-115
58. Heyes, M. P., Saito, K., and Markey, S. P. (1992) Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283, 633-635
59. Sei, S., Saito, K., Stewart, S. K., Crowley, J. S., Brouwers, P., Kleiner, D. E., Pizzo, P. A., and Heyes, M.P. (1995) Increased HIV-1 DNA content and quinolinic acid concentrations in brain tissues obtained from AIDS patients with HIV-encephalopathy. J. Infect Dis. 172, 638-647
60. Namboodiri, A. M., Venkateshan, C. N., Narayanan, R., Blinder, K., Moffett, J. R., Gajdusek, D. C., Gravell, M., and Gibbs, C. J. (1996) Increased quinolinate immunoreactivity in the peripheral blood monocytes/macrophages from SIV-infected monkeys. J. Neurovirol. 2, 433-438
61. Kerr, S.J., Armati, P. J., Pemberton, L. A., Smythe, G., Tattam, B., and Brew, B. J. (1997) Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology 49, 1671-1681
62. Saito, K., Nowak, T. S., Suyama, K., Quearry, B. J., Saito, M., Crowley, J. S., Markey, S. P., and Heyes, M.P. (1993) Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J. Neurochem. 61, 2061-2070
63. Saito, K., Quearry, B. J., Saito, M., Nowak, T. S., Markey, S. P., and Heyes, M. P. (1993) Kynurenine-3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch. Biochem. Biophys. 4, 307, 104-109
64. Milstien, S., Sakai, N., Kaufman, S., Brew, B.J., Krieger, C., Vickers, J. H., Saito, K., and Heyes, M. P. (1994) Cerebrospinal fluid nitrate/nirite te levels in neurologic diseases. J. Neurochem. 63, 1178-1180
65. Basile, A. S., Saito, K., Al-Mardini, H., Record, C. O., Hughes, R. D., Williams, R., Li Y., and Heyes, M. P. (1995) The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology 108, 818-823
66. Vogelgesang, S. A., Heyes, M. P., West S. G., Salazar A. M., Sfikakis P. P., Lipnick R. N., Klipple G. L., and Tsokos G. C. (1996) Quinolinic acid in patients with systemic lupus erythematqsus and neuropsychiatrie manifestations. J. Rheumatol. 23, 850-855
67. Achim C.L., Heyes, M. P., and Wiley C. A. (1993) Quantitation of human immunodeficiency virus, immune activation factors and quinolinic acid in AIDS brains. J. Clin. Invest. 91, 2769-2775
68. Heyes, M. P., Wyler A. R., Devinsky Q., Yergey J. A., Markey S. P., and Nadi S. (1990) Quinolinic acid concentrations in brain and cerebrpspinal fluid of patients with intractable complex partial seizures. Epilepsia 31, 172-177
69. Demitrack M. A., Heyes, M. P., Altemus M., Pigott T. A., and Gold P. W. (1995) Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: Relation to clinical and biochemical variables. Biol. Psychiatr. 37, 512-520
70. Heyes, M. P., Rubinow D., Lane C., and Markey S. P. (1989) Cerebrospinal fluid quinolinic acid concentrations arc increased in acquired immune deficiency syndrome. Ann. Neuwl. 26, 275-277
71. Reinhard J. F., Erickson J. B., and Flanagan E. M. (1994) Quinolinic acid in neurological disease: opportunities for novel drug discovery. Adv. Pharmacol. 30, 85-127
72. Yates J. R., Blight A. R., Mekonnen B., and Heyes, M. P. (1997) Sustained improvement follow ig suppression of local quinolinic acid synthesis in injured spinal cord. Soc. Neurosci. 23, 1384.